Xanté Releases High-Capacity, Wide-Format Production Printer

 Xanté recently announced the availability of the XR126 roll-to-roll printer, a high-capacity, roll-fed, wide-format production printer designed to meet all the needs of professional sign printers in one device. It is engineered to extend the proven quality, performance and reliability of Xanté UV flatbeds into a 10-ft roll-to-roll format. The XR126 features up to four Epson i3200 printheads, Xanté HDUV inks, and Adobe PostScript iQueue Workflow. XR126 key highlights include Adobe PostScript imaging, industrial Epson i3200 printheads, up to 126-inch roll capacity and mult-roll efficiency. By standardizing on the Epson i3200 printheads, Xanté inks and the iQueue Workflow, operators move between flatbed and roll jobs seamlessly. Shops consolidate consumables, maintain a single color standard and route jobs dynamically using the same interface and service model. “We desired to create a roll-to-roll UV printer that literally performs every roll media print task needed by our customers,” said Robert C. Ross Jr., president and CEO of Xanté. 

Read More

Helmsing Leach Attorneys Named To Best Lawyers In America List

Helmsing Leach Attorneys Named To Best Lawyers In America List

Pilots For Christ Again Hosting Sunflower Fundraiser

Pilots For Christ Again Hosting Sunflower Fundraiser

USA Health Contracts With Unitedhealthcare Set To Expire

USA Health Contracts With Unitedhealthcare Set To Expire

Baldwin Bone & Joint To Host Chronic Pain Seminar

Baldwin Bone & Joint To Host Chronic Pain Seminar

Baldwin Health Adds Lazenby

Baldwin Health Adds Lazenby

Brookley By The Bay, Marina Update

Brookley By The Bay, Marina Update

Foley Announces Campus Master Plan

Foley Announces Campus Master Plan

Naturenauts STEM Day Coming To Bellingrath

Naturenauts STEM Day Coming To Bellingrath

UM Completes Library Renovation

UM Completes Library Renovation

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.